{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:39:34Z","timestamp":1793813974832,"version":"4.6.1"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics &amp; Antimicro. Prot."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12602-026-10934-x","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T02:32:14Z","timestamp":1770604334000},"page":"6459-6472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lactic Acid Bacteria-derived Bacteriocins: A Promising Antimicrobial Strategy against Multidrug-resistant for Neonatal Sepsis Pathogens"],"prefix":"10.1007","volume":"18","author":[{"given":"Vijay","family":"Laxmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetal","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimala","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Mohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayhind","family":"Maury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Mohd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"5","key":"10934_CR1","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1016\/S2214-109X(22)00043-2","volume":"10","author":"R Milton","year":"2022","unstructured":"Milton R et al (2022) Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study. Lancet Glob Health 10(5):e661\u2013e672","journal-title":"Lancet Glob Health"},{"issue":"10449","key":"10934_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0140-6736(24)00495-1","volume":"404","author":"T Strunk","year":"2024","unstructured":"Strunk T et al (2024) Neonatal bacterial sepsis. Lancet 404(10449):277\u2013293","journal-title":"Lancet"},{"issue":"8","key":"10934_CR3","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/archdischild-2020-320217","volume":"106","author":"C Fleischmann","year":"2021","unstructured":"Fleischmann C et al (2021) Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis. Arch Dis Child 106(8):745\u2013752","journal-title":"Arch Dis Child"},{"key":"10934_CR4","doi-asserted-by":"crossref","unstructured":"Fleischmann-Struzek C et al (2018) The global burden of paediatric and neonatal sepsis: a systematic review. 6(3):223\u2013230","DOI":"10.1016\/S2213-2600(18)30063-8"},{"issue":"3","key":"10934_CR5","first-page":"225","volume":"28","author":"AC Seale","year":"2015","unstructured":"Seale AC, Obiero CW, Berkley JA (2015) Ration Dev Guidelines Manage Neonatal Sepsis Developing Ctries 28(3):225\u2013230","journal-title":"Ration Dev Guidelines Manage Neonatal Sepsis Developing Ctries"},{"issue":"9","key":"10934_CR6","doi-asserted-by":"publisher","first-page":"e054491","DOI":"10.1136\/bmjopen-2021-054491","volume":"12","author":"CM Bech","year":"2022","unstructured":"Bech CM et al (2022) Risk factors for neonatal sepsis in Sub-Saharan africa: a systematic review with meta-analysis. BMJ Open 12(9):e054491","journal-title":"BMJ Open"},{"issue":"10104","key":"10934_CR7","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/S0140-6736(17)31002-4","volume":"390","author":"AL Shane","year":"2017","unstructured":"Shane AL, S\u00e1nchez PJ, Stoll BJ (2017) Neonatal sepsis. Lancet 390(10104):1770\u20131780","journal-title":"Lancet"},{"key":"10934_CR8","doi-asserted-by":"crossref","unstructured":"Mulakoli F (2025) Global Trends in Neonatal Sepsis: A Scopus Bibliometric Analysis of Publications from 2015 to 2025.","DOI":"10.5772\/intechopen.1013122"},{"key":"10934_CR9","doi-asserted-by":"crossref","unstructured":"Pusdekar YV et al (2020) Rates and risk factors for preterm birth and low birthweight in the global network sites in six low-and low middle-income countries. 17(Suppl 3): p. 187","DOI":"10.1186\/s12978-020-01029-z"},{"key":"10934_CR10","unstructured":"Mahmoud HAH et al (2023) Insight into Neonatal Sepsis: Overv 15(9)"},{"key":"10934_CR11","doi-asserted-by":"crossref","unstructured":"Acharya R, Gathwala G, Sharma MJC (2025) Rapid identification of neonatal sepsis pathogens using MALDI-TOF MS: bacteriological profile and antimicrobial susceptibility patterns in a North. Indian Tert Care Hosp 17(5)","DOI":"10.7759\/cureus.83436"},{"key":"10934_CR12","doi-asserted-by":"crossref","unstructured":"Stritzke A et al (2022) Antimicrobial stewardship at birth in preterm infants: not just about a decrease! 41(5):394\u2013400","DOI":"10.1097\/INF.0000000000003462"},{"issue":"6","key":"10934_CR13","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1097\/INF.0000000000004815","volume":"44","author":"A Dramowski","year":"2025","unstructured":"Dramowski A et al (2025) Neonatal Sepsis in Low-and Middle-income Countries: Where Are We Now? Pediatr Infect Dis J 44(6):e207\u2013e210","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10934_CR14","first-page":"604","volume":"24","author":"S Kumar","year":"2025","unstructured":"Kumar S, Ray P, R.J.A.o.A M, Sahana (2025) Emerg Trend Multidrug-resistant Organisms Causing Sepsis Ventilated Newborns 24(3):604\u2013609","journal-title":"Emerg Trend Multidrug-resistant Organisms Causing Sepsis Ventilated Newborns"},{"key":"10934_CR15","doi-asserted-by":"crossref","unstructured":"Licona G et al (2023) Multidrug-resistant bacterial infections among very low birthweight infants with late-onset sepsis in Johannesburg, South Africa. Open forum infectious diseases. Oxford University Press US","DOI":"10.1093\/ofid\/ofad362"},{"key":"10934_CR16","doi-asserted-by":"crossref","unstructured":"Fang P et al (2023) Prevalence of multidrug-resistant pathogens causing neonatal early and late onset sepsis, a retrospective study from the tertiary referral children\u2019s hospital. : pp. 4213\u20134225","DOI":"10.2147\/IDR.S416020"},{"key":"10934_CR17","doi-asserted-by":"crossref","unstructured":"Chaurasia S et al (2019) Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance. 364","DOI":"10.1136\/bmj.k5314"},{"key":"10934_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-025-05562-2","author":"D Kainth","year":"2025","unstructured":"Kainth D, Thukral AJIJoP (2025) The looming threat of multidrug-resistant neonatal sepsis\u2013a wake-up call. Indian J Pediatr. https:\/\/doi.org\/10.1007\/s12098-025-05562-2","journal-title":"Indian J Pediatr"},{"key":"10934_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fcimb.2019.00085","volume":"9","author":"JGE Henderickx","year":"2019","unstructured":"Henderickx JGE et al (2019) The preterm gut microbiota: an inconspicuous challenge in nutritional neonatal care. Front Cell Infect Microbiol 9:85","journal-title":"Front Cell Infect Microbiol"},{"key":"10934_CR20","doi-asserted-by":"crossref","unstructured":"Bansal N et al (2023) Pharmacokinetics of drugs: newborn perspective. 2023. 7","DOI":"10.21037\/pm-22-11"},{"issue":"7","key":"10934_CR21","first-page":"687","volume":"43","author":"M Gashaw","year":"2024","unstructured":"Gashaw M et al (2024) Neonatal sepsis due to Multidrug-resistant bacteria at a tertiary teaching. Hosp Ethiopia 43(7):687\u2013693","journal-title":"Hosp Ethiopia"},{"issue":"4","key":"10934_CR22","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1365-2672.2012.05338.x","volume":"113","author":"M Hassan","year":"2012","unstructured":"Hassan M et al (2012) Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance. J Appl Microbiol 113(4):723\u2013736","journal-title":"J Appl Microbiol"},{"key":"10934_CR23","doi-asserted-by":"publisher","first-page":"111163","DOI":"10.1016\/j.foodres.2022.111163","volume":"156","author":"S Toushik","year":"2022","unstructured":"Toushik S et al (2022) Antibiofilm efficacy of leuconostoc mesenteroides J.27-derived postbiotic and food-grade essential oils against vibrio parahaemolyticus, Pseudomonas aeruginosa, and Escherichia coli alone and in combination, and their application as a green preservative in the seafood industry. Food Res Int 156:111163","journal-title":"Food Res Int"},{"issue":"17","key":"10934_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24173152","volume":"24","author":"RE Duval","year":"2019","unstructured":"Duval RE, Grare M, Demor\u00e9 BJM (2019) Fight against antimicrobial resistance: we always need new antibacterials but for right bacteria. Molecules 24(17):3152","journal-title":"Molecules"},{"issue":"2","key":"10934_CR25","first-page":"95","volume":"11","author":"PD Cotter","year":"2013","unstructured":"Cotter PD, Ross RP, C.J.N.R M, Hill (2013) Bacteriocins\u2014a Viable Altern antibiotics? 11(2):95\u2013105","journal-title":"Bacteriocins\u2014a Viable Altern antibiotics?"},{"issue":"5","key":"10934_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8050639","volume":"8","author":"A Simons","year":"2020","unstructured":"Simons A, Alhanout K, Duval REJM (2020) Bacteriocins, antimicrobial peptides from bacterial origin: overview of their biology and their impact against multidrug-resistant bacteria. Microorganisms 8(5):639","journal-title":"Microorganisms"},{"issue":"6","key":"10934_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12060956","volume":"12","author":"C Poggi","year":"2023","unstructured":"Poggi C, Dani CJA (2023) New antimicrobials for the treatment of neonatal sepsis caused by multi-drug-resistant bacteria: a systematic review. Antibiotics 12(6):956","journal-title":"Antibiotics"},{"key":"10934_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020196","author":"G Gradisteanu Pircalabioru","year":"2021","unstructured":"Gradisteanu Pircalabioru G et al (2021) Bacteriocins in the era of antibiotic resistance: rising to the challenge. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13020196","journal-title":"Pharmaceutics"},{"key":"10934_CR29","doi-asserted-by":"publisher","first-page":"630695","DOI":"10.3389\/fmicb.2021.630695","volume":"12","author":"DF Ben\u00edtez-Chao","year":"2021","unstructured":"Ben\u00edtez-Chao DF et al (2021) Bacteriocins: an overview of antimicrobial, Toxicity, and biosafety assessment by in vivo models. Front Microbiol 12:630695","journal-title":"Front Microbiol"},{"key":"10934_CR30","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.3389\/fimmu.2019.02910","volume":"10","author":"C Tirone","year":"2019","unstructured":"Tirone C et al (2019) Gut and lung microbiota in preterm infants: immunological modulation and implication in neonatal outcomes. Front Immunol 10:2910","journal-title":"Front Immunol"},{"key":"10934_CR31","doi-asserted-by":"crossref","unstructured":"Le TT et al (2025) Current state of microbiota clinical applications in neonatal and pediatric bacterial infections. 17(1):2529400","DOI":"10.1080\/19490976.2025.2529400"},{"issue":"11","key":"10934_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ph16111615","volume":"16","author":"G Muteeb","year":"2023","unstructured":"Muteeb G et al (2023) Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review. Pharmaceuticals 16(11):1615","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10934_CR33","doi-asserted-by":"publisher","first-page":"e24093","DOI":"10.1002\/jcla.24093","volume":"36","author":"A Darbandi","year":"2022","unstructured":"Darbandi A et al (2022) Bacteriocins: properties and potential use as antimicrobials. J Clin Lab Anal 36(1):e24093","journal-title":"J Clin Lab Anal"},{"key":"10934_CR34","doi-asserted-by":"publisher","first-page":"709959","DOI":"10.3389\/fmicb.2021.709959","volume":"12","author":"N Khorshidian","year":"2021","unstructured":"Khorshidian N et al (2021) Antibacterial activity of pediocin and pediocin-Producing bacteria against Listeria monocytogenes in meat products. Front Microbiol 12:709959","journal-title":"Front Microbiol"},{"issue":"7","key":"10934_CR35","first-page":"3919","volume":"11","author":"J Lei","year":"2019","unstructured":"Lei J et al (2019) Antimicrob Peptides their Potential Clin Appl 11(7):3919","journal-title":"Antimicrob Peptides their Potential Clin Appl"},{"issue":"1","key":"10934_CR36","first-page":"285","volume":"22","author":"SO Aremu","year":"2025","unstructured":"Aremu SO et al (2025) Application of diagnostic network optimization [DNOs] to tackle antimicrobial resistance. Sub-Saharan Afr 22(1):285","journal-title":"Sub-Saharan Afr"},{"issue":"9","key":"10934_CR37","first-page":"4124","volume":"26","author":"X Chen","year":"2025","unstructured":"Chen X et al (2025) Lactic Acid Bacteria Bacteriocins: Safe Effective Antimicrob Agents 26(9):4124","journal-title":"Lactic Acid Bacteria Bacteriocins: Safe Effective Antimicrob Agents"},{"issue":"1","key":"10934_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s44307-025-00059-7","volume":"3","author":"C Dai","year":"2025","unstructured":"Dai C et al (2025) An alternative approach to combat multidrug-resistant bacteria: new insights into traditional Chinese medicine monomers combined with antibiotics. Adv Biotechnol 3(1):6","journal-title":"Adv Biotechnol"},{"key":"10934_CR39","doi-asserted-by":"publisher","DOI":"10.2147\/RRTM.S410785","author":"S Sturrock","year":"2023","unstructured":"Sturrock S et al (2023) Improving the treatment of neonatal sepsis in resource-limited settings: gaps and recommendations. Res Rep Trop Med. https:\/\/doi.org\/10.2147\/RRTM.S410785","journal-title":"Res Rep Trop Med"},{"issue":"3","key":"10934_CR40","doi-asserted-by":"publisher","DOI":"10.15414\/jmbfs.3733","volume":"11","author":"K Sharma","year":"2021","unstructured":"Sharma K et al (2021) Classification and mechanism of bacteriocin induced cell death: a review: bacteriocin classification and their mode action. J Microbiol Biotechnol Food Sci 11(3):e3733-e3733","journal-title":"J Microbiol Biotechnol Food Sci"},{"issue":"3","key":"10934_CR41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1574-6976.2001.tb00579.x","volume":"25","author":"O McAuliffe","year":"2001","unstructured":"McAuliffe O, Ross RP, Hill C (2001) Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol Rev 25(3):285\u2013308","journal-title":"FEMS Microbiol Rev"},{"key":"10934_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-981-97-3413-9_2","volume-title":"Antimicrobial Peptides from Lactic Acid Bacteria: Diversity, Biosynthesis and Applications","author":"NS Castrej\u00f3n-Jim\u00e9nez","year":"2024","unstructured":"Castrej\u00f3n-Jim\u00e9nez NS (2024) Classification of bacteriocins from lactic acid bacteria and their mode of action. Antimicrobial Peptides from Lactic Acid Bacteria: Diversity, Biosynthesis and Applications. Springer, pp 33\u201365"},{"key":"10934_CR43","doi-asserted-by":"crossref","unstructured":"Manoharan M, T.S.J.J.o.T B, Balasubramanian, Biotechnology (2022) Extensive Rev Prod Purif Bioactive Application Different Classes Bacteriocin 7(3)","DOI":"10.22146\/jtbb.72735"},{"key":"10934_CR44","unstructured":"Scadden J (2022) New antimicrobials to target gut pathogens. University of East Anglia"},{"issue":"1","key":"10934_CR45","first-page":"e24093","volume":"36","author":"A Darbandi","year":"2022","unstructured":"Darbandi A et al (2022) Bacteriocins: Prop Potential Use as Antimicrobials 36(1):e24093","journal-title":"Bacteriocins: Prop Potential Use as Antimicrobials"},{"key":"10934_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodcont.2023.109682","volume":"148","author":"Z Peng","year":"2023","unstructured":"Peng Z et al (2023) Identification and characterization of a novel pH and heat stable bacteriocin-like substance lactococcin036019 with food preserving potential. Food Control 148:109682","journal-title":"Food Control"},{"issue":"1","key":"10934_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02868-w","volume":"7","author":"B Mesa-Pereira","year":"2017","unstructured":"Mesa-Pereira B et al (2017) Controlled functional expression of the bacteriocins pediocin PA-1 and bactofencin A in Escherichia coli. Sci Rep 7(1):3069","journal-title":"Sci Rep"},{"issue":"1","key":"10934_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10068-021-00986-w","volume":"31","author":"BR Sharma","year":"2022","unstructured":"Sharma BR, Halami PM, Tamang JP (2022) Novel pathways in bacteriocin synthesis by lactic acid bacteria with special reference to ethnic fermented foods. Food Sci Biotechnol 31(1):1\u201316","journal-title":"Food Sci Biotechnol"},{"key":"10934_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34692","author":"H Kadkhoda","year":"2024","unstructured":"Kadkhoda H et al (2024) Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34692","journal-title":"Heliyon"},{"issue":"3","key":"10934_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ph18030402","volume":"18","author":"ME Elshobary","year":"2025","unstructured":"Elshobary ME et al (2025) <Emphasis Type=\"Italic\">Combating antibiotic resistance: mechanisms, multidrug-resistant pathogens, and novel therapeutic approaches: an updated review.<\/Emphasis>. Pharmaceuticals 18(3):402","journal-title":"Pharmaceuticals"},{"key":"10934_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1528583","volume":"15","author":"M Sadeeq","year":"2025","unstructured":"Sadeeq M et al (2025) <Emphasis Type=\"Italic\">Unlocking the power of antimicrobial peptides: advances in production, optimization, and therapeutics.<\/Emphasis>. Front Cell Infect Microbiol 15:1528583","journal-title":"Front Cell Infect Microbiol"},{"key":"10934_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13070666","author":"MA Solis-Balandra","year":"2024","unstructured":"Solis-Balandra MA, Sanchez-Salas JL (2024) <Emphasis Type=\"Italic\">Classification and multi-functional use of bacteriocins in health, biotechnology, and food industry.<\/Emphasis>. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics13070666","journal-title":"Antibiotics"},{"key":"10934_CR53","doi-asserted-by":"publisher","first-page":"110826","DOI":"10.1016\/j.lwt.2020.110826","volume":"140","author":"H-W Li","year":"2021","unstructured":"Li H-W et al (2021) A novel bacteriocin from Lactobacillus salivarius against Staphylococcus aureus: Isolation, purification, identification, antibacterial and antibiofilm activity. LWT 140:110826","journal-title":"LWT"},{"issue":"12","key":"10934_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-022-03061-7","volume":"79","author":"A Parmanik","year":"2022","unstructured":"Parmanik A et al (2022) <Emphasis Type=\"Italic\">Current treatment strategies against multidrug-resistant bacteria: a review.<\/Emphasis>. Curr Microbiol 79(12):388","journal-title":"Curr Microbiol"},{"issue":"6","key":"10934_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12061072","volume":"12","author":"A Kontou","year":"2023","unstructured":"Kontou A et al (2023) <Emphasis Type=\"Italic\">Use of newer and repurposed antibiotics against gram-negative bacteria in neonates.<\/Emphasis>. Antibiotics 12(6):1072","journal-title":"Antibiotics"},{"issue":"2","key":"10934_CR56","first-page":"196","volume":"13","author":"G Gradisteanu Pircalabioru","year":"2021","unstructured":"Gradisteanu Pircalabioru G et al (2021) Bacteriocins Era Antibiotic Resistance: Rising Chall 13(2):196","journal-title":"Bacteriocins Era Antibiotic Resistance: Rising Chall"},{"issue":"9","key":"10934_CR57","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.clinthera.2020.06.011","volume":"42","author":"AM Newman","year":"2020","unstructured":"Newman AM, Arshad MJCt (2020) <Emphasis Type=\"Italic\">The role of probiotics, prebiotics and synbiotics in combating multidrug-resistant organisms.<\/Emphasis>. Clin Ther 42(9):1637\u20131648","journal-title":"Clin Ther"},{"issue":"1","key":"10934_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuaa039","volume":"45","author":"S Soltani","year":"2021","unstructured":"Soltani S et al (2021) <Emphasis Type=\"Italic\">Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations.<\/Emphasis>. FEMS Microbiol Rev 45(1):fuaa039","journal-title":"FEMS Microbiol Rev"},{"issue":"7","key":"10934_CR59","first-page":"1521","volume":"13","author":"SVJL Guryanova","year":"2023","unstructured":"Guryanova SVJL (2023) Immunomodulation Bioavailab Saf Bacteriocins 13(7):1521","journal-title":"Immunomodulation Bioavailab Saf Bacteriocins"},{"issue":"11","key":"10934_CR60","doi-asserted-by":"publisher","first-page":"103870","DOI":"10.1016\/j.xphs.2025.103870","volume":"114","author":"S Shadbar","year":"2025","unstructured":"Shadbar S et al (2025) Immunogenicity risk mitigation of therapeutic proteins with translational immunogenicity, analytical characterization, and regulatory insight. J Pharm Sci 114(11):103870","journal-title":"J Pharm Sci"},{"issue":"19","key":"10934_CR61","first-page":"3145","volume":"11","author":"SD Todorov","year":"2022","unstructured":"Todorov SD et al (2022) Use of bacteriocins and bacteriocinogenic beneficial organisms in food products: benefits. Challenges Concerns 11(19):3145","journal-title":"Challenges Concerns"},{"issue":"2","key":"10934_CR62","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3390\/encyclopedia3020040","volume":"3","author":"HN Rabetafika","year":"2023","unstructured":"Rabetafika HN et al (2023) <Emphasis Type=\"Italic\">Probiotics as antibiotic alternatives for human and animal applications.<\/Emphasis>. Encyclopedia 3(2):561\u2013581","journal-title":"Encyclopedia"},{"issue":"1","key":"10934_CR63","first-page":"22","volume":"48","author":"A Ben Lagha","year":"2017","unstructured":"Ben Lagha A et al (2017) Antimicrob Potential Bacteriocins Poult Swine Prod 48(1):22","journal-title":"Antimicrob Potential Bacteriocins Poult Swine Prod"},{"issue":"1","key":"10934_CR64","first-page":"23","volume":"13","author":"A Campion","year":"2013","unstructured":"Campion A et al (2013) In vivo activity of Nisin A and Nisin V against Listeria. Monocytogenes Mice 13(1):23","journal-title":"Monocytogenes Mice"},{"issue":"1","key":"10934_CR65","first-page":"1","volume":"6","author":"C Piper","year":"2009","unstructured":"Piper C et al (2009) Discovery Medically Signif Lantibiotics 6(1):1\u201318","journal-title":"Discovery Medically Signif Lantibiotics"},{"issue":"4","key":"10934_CR66","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/jac\/dkm009","volume":"59","author":"FE Lopez","year":"2007","unstructured":"Lopez FE et al (2007) <Emphasis Type=\"Italic\">Efficacy of microcin J25 in biomatrices and in a mouse model of Salmonella infection.<\/Emphasis>. J Antimicrob Chemother 59(4):676\u2013680","journal-title":"J Antimicrob Chemother"},{"key":"10934_CR67","doi-asserted-by":"crossref","unstructured":"Ben\u00edtez-Chao DF et al (2021) Bacteriocins: an overview of antimicrobial, toxicity, and biosafety assessment by in vivo models. 12:p630695","DOI":"10.3389\/fmicb.2021.630695"},{"issue":"1","key":"10934_CR68","first-page":"151","volume":"42","author":"AB Shah","year":"2025","unstructured":"Shah AB, Shim SHJNPR (2025) Hum Microbiota Peptides: Important Roles Hum Health 42(1):151\u2013194","journal-title":"Hum Microbiota Peptides: Important Roles Hum Health"},{"key":"10934_CR69","doi-asserted-by":"crossref","unstructured":"Choi GH et al (2025) Antimicrobial peptides (bacteriocins) produced by Lactococcus lactis and pediococcus Pentosaceus strains with activity against clinical and food-borne pathogens. 17(3):1171\u20131192","DOI":"10.1007\/s12602-023-10188-x"},{"key":"10934_CR70","doi-asserted-by":"crossref","unstructured":"Lyu Z et al (2023) Biological function of antimicrobial peptides on suppressing pathogens and improving host immunity. 12(6):1037","DOI":"10.3390\/antibiotics12061037"},{"key":"10934_CR71","doi-asserted-by":"crossref","unstructured":"Helmy YA et al (2023) Antimicrobial resistance and recent alternatives to antibiotics for the control of bacterial pathogens with an emphasis on foodborne pathogens. 12(2):274","DOI":"10.3390\/antibiotics12020274"},{"key":"10934_CR72","doi-asserted-by":"crossref","unstructured":"Love MJ et al (2018) Potential for bacteriophage endolysins to supplement or replace antibiotics in food production and clinical care. Antibiot (Basel), 7(1)","DOI":"10.3390\/antibiotics7010017"},{"issue":"64","key":"10934_CR73","doi-asserted-by":"publisher","first-page":"38937","DOI":"10.1039\/D0RA06161A","volume":"10","author":"ZJ Ng","year":"2020","unstructured":"Ng ZJ et al (2020) Application of bacteriocins in food preservation and infectious disease treatment for humans and livestock: a review. RSC Adv 10(64):38937\u201338964","journal-title":"RSC Adv"},{"key":"10934_CR74","unstructured":"Thakur D, Kumar L (2025) Biofilm-associated Escherichia coli infections: pathogenesis, clinical implications, and treatment strategies. Crit Rev Microbiol, : p. 1\u201345"},{"key":"10934_CR75","doi-asserted-by":"publisher","first-page":"1554061","DOI":"10.3389\/frabi.2025.1554061","volume":"4","author":"M Oliveira","year":"2025","unstructured":"Oliveira M et al (2025) Non-antibiotic therapies for multidrug-resistant Gastrointestinal infections: an overview of the use of probiotics, natural compounds, and bacteriophages. Front Antibiot 4:1554061","journal-title":"Front Antibiot"},{"issue":"1","key":"10934_CR76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13065-024-01129-y","volume":"18","author":"M Nasaj","year":"2024","unstructured":"Nasaj M et al (2024) Vancomycin and nisin-modified magnetic Fe(3)O(4)@SiO(2) nanostructures coated with Chitosan to enhance antibacterial efficiency against methicillin resistant Staphylococcus aureus (MRSA) infection in a murine superficial wound model. BMC Chem 18(1):43","journal-title":"BMC Chem"},{"key":"10934_CR77","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.nbt.2024.07.005","volume":"83","author":"TK Joishy","year":"2024","unstructured":"Joishy TK et al (2024) Probiotic and anti-inflammatory properties of Lactiplantibacillus plantarum MKTJ24 isolated from an artisanal fermented fish of North-east India. New Biotechnol 83:121\u2013132","journal-title":"New Biotechnol"},{"key":"10934_CR78","doi-asserted-by":"crossref","unstructured":"Field D et al (2019) Bioengineering Nisin to overcome the Nisin resistance protein. 111(3):717\u2013731","DOI":"10.1111\/mmi.14183"},{"key":"10934_CR79","doi-asserted-by":"crossref","unstructured":"Mathur H et al (2017) Bacteriocin-antimicrobial synergy: a medical and food perspective. 8:p1205","DOI":"10.3389\/fmicb.2017.01205"},{"key":"10934_CR80","first-page":"103","volume":"5","author":"AI Gomaa","year":"2017","unstructured":"Gomaa AI et al (2017) Dual Coat Liposomes as Encapsulating Matrix Antimicrob Peptides: Dev Charact 5:103","journal-title":"Dual Coat Liposomes as Encapsulating Matrix Antimicrob Peptides: Dev Charact"},{"key":"10934_CR81","doi-asserted-by":"crossref","unstructured":"Ongey EL et al (2017) Pharmacological and Pharmacokinetic properties of lanthipeptides undergoing clinical studies. 39(4):473\u2013482","DOI":"10.1007\/s10529-016-2279-9"},{"key":"10934_CR82","doi-asserted-by":"crossref","unstructured":"Anjana, Tiwari SK (2022) Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota. Volume 12\u20132022","DOI":"10.3389\/fcimb.2022.851140"},{"key":"10934_CR83","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuaa039","author":"S Soltani","year":"2021","unstructured":"Soltani S et al (2021) Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations. FEMS Microbiol Rev. https:\/\/doi.org\/10.1093\/femsre\/fuaa039","journal-title":"FEMS Microbiol Rev"},{"key":"10934_CR84","doi-asserted-by":"publisher","first-page":"610997","DOI":"10.3389\/fmedt.2020.610997","volume":"2","author":"AH Benfield","year":"2020","unstructured":"Benfield AH, Henriques ST (2020) Mode-of-Action of antimicrobial peptides: membrane disruption vs. Intracellular mechanisms. Front Med Technol 2:610997","journal-title":"Front Med Technol"},{"key":"10934_CR85","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00052-18","author":"Q Li","year":"2018","unstructured":"Li Q, Montalban-Lopez M, Kuipers OP (2018) Increasing the antimicrobial activity of nisin-based lantibiotics against gram-negative pathogens. Appl Environ Microbiol. https:\/\/doi.org\/10.1128\/AEM.00052-18","journal-title":"Appl Environ Microbiol"},{"issue":"6","key":"10934_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22062885","volume":"22","author":"A Zimna","year":"2021","unstructured":"Zimna A et al (2021) An insight into the stages of ion leakage during red blood cell storage. Int J Mol Sci 22(6):2885","journal-title":"Int J Mol Sci"},{"key":"10934_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/membranes12111166","author":"DN Chernyshova","year":"2022","unstructured":"Chernyshova DN et al (2022) Discovery of the potentiator of the pore-forming ability of lantibiotic nisin: perspectives for anticancer therapy. Membranes. https:\/\/doi.org\/10.3390\/membranes12111166","journal-title":"Membranes"},{"issue":"2","key":"10934_CR88","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00294-017-0757-9","volume":"64","author":"NS Rios Colombo","year":"2018","unstructured":"Rios Colombo NS et al (2018) Pediocin-like bacteriocins: new perspectives on mechanism of action and immunity. Curr Genet 64(2):345\u2013351","journal-title":"Curr Genet"},{"key":"10934_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01690","volume":"10","author":"G Rodrigues","year":"2019","unstructured":"Rodrigues G et al (2019) Bacterial proteinaceous compounds with multiple activities toward cancers and microbial infection. Front Microbiol 10:1690","journal-title":"Front Microbiol"},{"issue":"10","key":"10934_CR90","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1128\/AEM.02602-10","volume":"77","author":"M Kjos","year":"2011","unstructured":"Kjos M, Nes IF, Diep DB (2011) Mechanisms of resistance to bacteriocins targeting the mannose phosphotransferase system. Appl Environ Microbiol 77(10):3335\u20133342","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"10934_CR91","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12602-017-9374-7","volume":"10","author":"S Chiorean","year":"2018","unstructured":"Chiorean S, Vederas JC, van Belkum MJ (2018) Identification and heterologous expression of the sec-Dependent bacteriocin faerocin MK from Enterococcus faecium M3K31. Probiotics Antimicrob Proteins 10(2):142\u2013147","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"4","key":"10934_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12040704","volume":"12","author":"J Che","year":"2024","unstructured":"Che J et al (2024) Elimination of pathogen biofilms via postbiotics from lactic acid bacteria: a promising method in food and biomedicine. Microorganisms 12(4):704","journal-title":"Microorganisms"},{"issue":"1","key":"10934_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101918","volume":"32","author":"A Alshweiat","year":"2024","unstructured":"Alshweiat A et al (2024) A significant antibiofilm and antimicrobial activity of chitosan-polyacrylic acid nanoparticles against pathogenic bacteria. Saudi Pharm J 32(1):101918","journal-title":"Saudi Pharm J"},{"key":"10934_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12030554","author":"A Fran\u00e7a","year":"2023","unstructured":"Fran\u00e7a A (2023) The role of coagulase-negative staphylococci biofilms on late-onset sepsis: current challenges and emerging diagnostics and therapies. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics12030554","journal-title":"Antibiotics"},{"key":"10934_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10020303","author":"S Nadar","year":"2022","unstructured":"Nadar S et al (2022) Development of antibiofilm therapeutics strategies to overcome antimicrobial drug resistance. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms10020303","journal-title":"Microorganisms"},{"key":"10934_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10061239","author":"RV Sionov","year":"2022","unstructured":"Sionov RV, Steinberg D (2022) Targeting the holy triangle of quorum sensing, biofilm formation, and antibiotic resistance in pathogenic bacteria. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms10061239","journal-title":"Microorganisms"},{"issue":"1","key":"10934_CR97","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s43556-023-00164-w","volume":"4","author":"X Wang","year":"2023","unstructured":"Wang X et al (2023) Biofilm formation: mechanistic insights and therapeutic targets. Mol Biomed 4(1):49","journal-title":"Mol Biomed"},{"key":"10934_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092995","author":"BS Lopes","year":"2022","unstructured":"Lopes BS et al (2022) The role of antimicrobial peptides as antimicrobial and antibiofilm agents in tackling the silent pandemic of antimicrobial resistance. Molecules. https:\/\/doi.org\/10.3390\/molecules27092995","journal-title":"Molecules"},{"key":"10934_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094124","author":"X Chen","year":"2025","unstructured":"Chen X et al (2025) Lactic acid bacteria bacteriocins: safe and effective antimicrobial agents. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26094124","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10934_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/fermentation11070410","volume":"11","author":"C Dudeja","year":"2025","unstructured":"Dudeja C et al (2025) Microbial genome editing with CRISPR\u2013Cas9: recent advances and emerging applications across sectors. Fermentation 11(7):410","journal-title":"Fermentation"},{"issue":"18","key":"10934_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26189146","volume":"26","author":"AS Rozanov","year":"2025","unstructured":"Rozanov AS et al (2025) Advances in genetic transformation of lactic acid bacteria: overcoming barriers and enhancing plasmid tools. Int J Mol Sci 26(18):9146","journal-title":"Int J Mol Sci"},{"issue":"17","key":"10934_CR102","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1128\/AEM.00342-08","volume":"74","author":"HB van den Berg","year":"2008","unstructured":"van den Berg HB et al (2008) Distinct contributions of the Nisin biosynthesis enzymes NisB and NisC and transporter NisT to Prenisin production by Lactococcus lactis. Appl Environ Microbiol 74(17):5541\u20135548","journal-title":"Appl Environ Microbiol"},{"issue":"Pt 5","key":"10934_CR103","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1099\/13500872-142-5-1281","volume":"142","author":"SR Ra","year":"1996","unstructured":"Ra SR et al (1996) Genes responsible for nisin synthesis, regulation and immunity form a regulon of two operons and are induced by nisin in Lactoccocus lactis N8. Microbiology (Reading) 142(Pt 5):1281\u20131288","journal-title":"Microbiology (Reading)"},{"key":"10934_CR104","doi-asserted-by":"publisher","first-page":"695081","DOI":"10.3389\/fmicb.2021.695081","volume":"12","author":"H Mathur","year":"2021","unstructured":"Mathur H et al (2021) Editorial: bacteriocins and other ribosomally synthesised and Post-translationally modified peptides (RiPPs) as alternatives to antibiotics. Front Microbiol 12:695081","journal-title":"Front Microbiol"},{"issue":"2","key":"10934_CR105","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11274-025-04278-x","volume":"41","author":"M Lou","year":"2025","unstructured":"Lou M et al (2025) Microbial production systems and optimization strategies of antimicrobial peptides: a review. World J Microbiol Biotechnol 41(2):66","journal-title":"World J Microbiol Biotechnol"},{"issue":"4","key":"10934_CR106","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.synbio.2020.08.001","volume":"5","author":"J Zhao","year":"2020","unstructured":"Zhao J, Fang H, Zhang D (2020) Expanding application of CRISPR-Cas9 system in microorganisms. Synth Syst Biotechnol 5(4):269\u2013276","journal-title":"Synth Syst Biotechnol"},{"key":"10934_CR107","doi-asserted-by":"publisher","first-page":"e201210003","DOI":"10.5936\/csbj.201210003","volume":"3","author":"M Papagianni","year":"2012","unstructured":"Papagianni M (2012) Metabolic engineering of lactic acid bacteria for the production of industrially important compounds. Comput Struct Biotechnol J 3:e201210003","journal-title":"Comput Struct Biotechnol J"},{"key":"10934_CR108","doi-asserted-by":"publisher","DOI":"10.1155\/tswj\/6659874","volume":"2025","author":"S Ait Assou","year":"2025","unstructured":"Ait Assou S, El Hassouni M (2025) New Streptomyces-derived antibacterial compounds targeting gram-positive bacteria: a systematic review. Sci World J 2025:6659874","journal-title":"Sci World J"},{"key":"10934_CR109","doi-asserted-by":"publisher","first-page":"740803","DOI":"10.1016\/j.aquaculture.2024.740803","volume":"587","author":"E Stavridou","year":"2024","unstructured":"Stavridou E et al (2024) Landscape of microalgae omics and metabolic engineering research for strain improvement: an overview. Aquaculture 587:740803","journal-title":"Aquaculture"},{"issue":"4","key":"10934_CR110","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/dna4040030","volume":"4","author":"P Yang","year":"2024","unstructured":"Yang P et al (2024) <Emphasis Type=\"Italic\">Genetic engineering in bacteria, fungi, and oomycetes, taking advantage of CRISPR.<\/Emphasis>. DNA 4(4):427\u2013454","journal-title":"DNA"},{"key":"10934_CR111","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3389\/fmicb.2018.01567","volume":"9","author":"L Yi","year":"2018","unstructured":"Yi L, Luo L, L\u00fc X (2018) Efficient exploitation of multiple novel bacteriocins by combination of complete genome and peptidome. Front Microbiol 9:1567","journal-title":"Front Microbiol"},{"key":"10934_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/nu15071566","author":"T Zhang","year":"2023","unstructured":"Zhang T, Zhang J, Duan L (2023) <Emphasis Type=\"Italic\">The role of genetically engineered probiotics for treatment of inflammatory bowel disease: a systematic review.<\/Emphasis>. Nutrients. https:\/\/doi.org\/10.3390\/nu15071566","journal-title":"Nutrients"},{"issue":"1","key":"10934_CR113","doi-asserted-by":"publisher","first-page":"2519696","DOI":"10.1080\/19490976.2025.2519696","volume":"17","author":"E Carolak","year":"2025","unstructured":"Carolak E et al (2025) Being a better version of yourself: genetically engineered probiotic bacteria as host defense enhancers in the control of intestinal pathogens. Gut Microbes 17(1):2519696","journal-title":"Gut Microbes"},{"key":"10934_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12030508","author":"D Rallis","year":"2023","unstructured":"Rallis D et al (2023) <Emphasis Type=\"Italic\">Fighting antimicrobial resistance in neonatal intensive care units: rational use of antibiotics in neonatal sepsis.<\/Emphasis>. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics12030508","journal-title":"Antibiotics"},{"issue":"10","key":"10934_CR115","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/17460913.2025.2520693","volume":"20","author":"SA Selvan","year":"2025","unstructured":"Selvan SA et al (2025) Commercial utilization of bacteriocins: tackling challenges and exploring their potential as alternatives to antibiotics. Future Microbiol 20(10):681\u2013693","journal-title":"Future Microbiol"},{"key":"10934_CR116","doi-asserted-by":"crossref","unstructured":"AL-Fawares Ol et al (2025) Development of Chitosan-Polyacrylic acid complex systems for enhanced oral delivery of Lactobacillus Gasseri and Bifidobacterium Bifidum probiotics. : pp. 585\u2013598","DOI":"10.2147\/DDDT.S478925"},{"issue":"1","key":"10934_CR117","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12967-025-06321-9","volume":"23","author":"S Zheng","year":"2025","unstructured":"Zheng S et al (2025) Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges. J Transl Med 23(1):292","journal-title":"J Transl Med"},{"key":"10934_CR118","doi-asserted-by":"crossref","unstructured":"Min KH et al (2024) Antimicrobial peptides and their biomedical applications: A review. Antibiot (Basel), 13(9)","DOI":"10.3390\/antibiotics13090794"},{"key":"10934_CR119","doi-asserted-by":"crossref","unstructured":"Wei J et al (2025) Next-generation probiotics and engineered BEVs for precision therapeutics in osteoporosis. Volume 12\u20132025","DOI":"10.3389\/fnut.2025.1581971"},{"key":"10934_CR120","first-page":"0017","volume":"5","author":"L Liu","year":"2023","unstructured":"Liu L, Helal SE, Peng N (2023) CRISPR-Cas-Based Eng Probiotics Biodes Res 5:0017","journal-title":"CRISPR-Cas-Based Eng Probiotics Biodes Res"},{"issue":"4","key":"10934_CR121","first-page":"001175","volume":"168","author":"JK Parker","year":"2022","unstructured":"Parker JK, Davies BWJM (2022) Microcins Reveal Nat Mech Bacterial Manipulation Inf Therapeutic Dev 168(4):001175","journal-title":"Microcins Reveal Nat Mech Bacterial Manipulation Inf Therapeutic Dev"},{"issue":"4","key":"10934_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12040676","volume":"12","author":"E-J Yi","year":"2023","unstructured":"Yi E-J, Kim A-JJA (2023) <Emphasis Type=\"Italic\">Antimicrobial and antibiofilm effect of bacteriocin-producing Pediococcus inopinatus K35 isolated from kimchi against multidrug-resistant Pseudomonas aeruginosa.<\/Emphasis>. Antibiotics 12(4):676","journal-title":"Antibiotics"},{"key":"10934_CR123","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3389\/fmicb.2018.00594","volume":"9","author":"CCG Silva","year":"2018","unstructured":"Silva CCG, Silva SPM, Ribeiro SC (2018) Application of bacteriocins and protective cultures in dairy food preservation. Front Microbiol 9:594","journal-title":"Front Microbiol"},{"issue":"8","key":"10934_CR124","first-page":"287","volume":"41","author":"V Stabnikov","year":"2025","unstructured":"Stabnikov V et al (2025) Recent Adv Study Prop Appl Lactic Acid Bacteria 41(8):287","journal-title":"Recent Adv Study Prop Appl Lactic Acid Bacteria"},{"issue":"6","key":"10934_CR125","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/1574-6976.12021","volume":"37","author":"K Selle","year":"2013","unstructured":"Selle K, Klaenhammer TRJFmr (2013) <Emphasis Type=\"Italic\">Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health.<\/Emphasis>. FEMS Microbiol Rev 37(6):915\u2013935","journal-title":"FEMS Microbiol Rev"},{"key":"10934_CR126","doi-asserted-by":"publisher","unstructured":"Haddad Kashani H et al (2018) Recombinant endolysins as potential therapeutics against antibiotic-resistant Staphylococcus aureus: current status of research and novel delivery strategies. 31(1). https:\/\/doi.org\/10.1128\/cmr. 00071\u2009\u2013\u200917","DOI":"10.1128\/cmr"},{"issue":"1","key":"10934_CR127","first-page":"4374891","volume":"2020","author":"AW Negash","year":"2020","unstructured":"Negash AW, B.A.J.I.J.o M, Tsehai (2020) Curr Appl Bacteriocin 2020(1):4374891","journal-title":"Curr Appl Bacteriocin"},{"issue":"1","key":"10934_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9010032","volume":"9","author":"E Meade","year":"2020","unstructured":"Meade E, Slattery MA, Garvey M (2020) Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile? Antibiotics 9(1):32","journal-title":"Antibiotics"},{"issue":"1","key":"10934_CR129","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13567-017-0425-6","volume":"48","author":"A Ben Lagha","year":"2017","unstructured":"Ben Lagha A et al (2017) Antimicrobial potential of bacteriocins in poultry and swine production. Vet Res 48(1):22","journal-title":"Vet Res"},{"issue":"1","key":"10934_CR130","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2180-13-23","volume":"13","author":"A Campion","year":"2013","unstructured":"Campion A et al (2013) In vivo activity of Nisin A and Nisin V against Listeria monocytogenesin mice. BMC Microbiol 13(1):23","journal-title":"BMC Microbiol"},{"issue":"16","key":"10934_CR131","first-page":"2947","volume":"70","author":"R Hammami","year":"2013","unstructured":"Hammami R et al (2013) Anti-infective Prop Bacteriocins: Update 70(16):2947\u20132967","journal-title":"Anti-infective Prop Bacteriocins: Update"},{"issue":"1","key":"10934_CR132","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.chembiol.2007.11.009","volume":"15","author":"F Castiglione","year":"2008","unstructured":"Castiglione F et al (2008) Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens. Chem Biol 15(1):22\u201331","journal-title":"Chem Biol"},{"issue":"7","key":"10934_CR133","first-page":"898","volume":"18","author":"E Gerstner","year":"2016","unstructured":"Gerstner E et al (2016) Highlights Literature 18(7):898\u2013901","journal-title":"Highlights Literature"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-10934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-10934-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-10934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T19:02:33Z","timestamp":1784055753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-10934-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":133,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10934"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-10934-x","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}